BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 18, 2025
Home » Blogs » BioWorld MedTech Perspectives » Green-eyed with med-tech envy

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Green-eyed with med-tech envy

April 22, 2011
By Amanda Pedersen

I’m not proud to admit this, but once in a while I do get bit by the green-eyed monster – only when it comes to medical innovation though. Hey, nobody’s perfect – right?

About eight years ago I had major colorectal surgery following a pretty wicked battle with ulcerative colitis. Basically the surgeon had to take out my entire colon, creating a stoma (artificial opening in the abdomen wall through which the end of the intestine is brought). I wore an ileostomy bag for 15 months before having a “take down” surgery so that I no longer needed the bag – in other words, they rerouted me. Don’t you just have all sorts of lovely images in your head right now?

Anyway, as a med-tech reporter, I occasionally come across a story about a new technology in the GI space designed to improve colorectal surgery or to make life a little easier for ostomy patients. Take the AOS-C1000 colostomy management system in development by Stimatix GI (Misgav, Israel) for instance. The AOS-C1000 is an artificial sphincter designed to allow individuals to discreetly manage their colostomy without the need to wear a traditional ostomy pouch. The company also plans to make a similar device for ileostomates (like I used to be) and urostomates. This could be the first major breakthrough in ostomy care in more than 50 years.

Don’t get me wrong, I’m thrilled to see these advancements being made and I’m happy for the patients whose quality of life will be greatly improved by it. But I can’t help but wish this technology had been available eight years ago. So yeah, sometimes I get a little green-eyed with med-tech envy.

I’m already bracing for Digestive Disease Week (May 7 – 10) when the latest R&D efforts on the GI horizon will be unveiled in Chicago. But all kidding aside, it really is exciting to see medical innovation taking place in any sector, but particularly the GI space because it hits so close to home.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 17, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 17, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing